Deferred Tax Assets, Valuation Allowance of Verona Pharma plc from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Verona Pharma plc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Verona Pharma plc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $98,522,000, a 77% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Verona Pharma plc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $98,522,000 +$42,999,000 +77% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q4 2023 $55,523,000 +$7,047,000 +15% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $48,476,000 +$18,224,000 +60% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $30,252,000 -$69,000 -0.23% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q4 2020 $30,321,000 +$16,817,000 +125% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q4 2019 $13,504,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.